Cosman, F, Kendler, D L, Langdahl, B L, Leder, B Z, Lewiecki, E M, Miyauchi, A, Rojeski, M, McDermott, M, Oates, M K, Milmont, C E, Libanati, C & Ferrari, S 2022, ' Romosozumab and antiresorptive treatment : the importance of treatment sequence ', Osteoporosis International, vol. 33, no. 6, pp. 1243-1256 . https://doi.org/10.1007/s00198-021-06174-0
McClung, M R, Bolognese, M A, Brown, J P, Reginster, J Y, Langdahl, B L, Maddox, J, Shi, Y, Rojeski, M, Meisner, P D & Grauer, A 2020, ' A single dose of zoledronate preserves bone mineral density for up to 2 years after a second course of romosozumab ', Osteoporosis International, vol. 31, no. 11, pp. 2231-2241 . https://doi.org/10.1007/s00198-020-05502-0 Osteoporosis International